Conclusions need to be derived from combinations of different models and the community has been proactive about sharing resources and insight to reach clinically meaningful conclusions and new treatment strategies have subsequently been devised for patients with mutant ESR1 cancers. This evidence concerns the gene ESR1 and cancer.